18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels.
about
Cabozantinib for progressive metastatic medullary thyroid cancer: a reviewNew imaging approaches to phaeochromocytomas and paragangliomas.Update on thyroid cancer treatment.Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.(18)F-Fluorine-18-l-dihydroxyphenylalanine ((18)F-DOPA) positive isolated peritoneal carcinomatosis from a MENII-related medullary thyroid carcinoma. About an atypical metastatic site and utility of (18)F-FDOPA.PET in the follow-up of differentiated thyroid cancer.Correlation between Calcitonin Levels and [(18)F]FDG-PET/CT in the Detection of Recurrence in Patients with Sporadic and Hereditary Medullary Thyroid CancerReview of fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinomas.Positron emission tomography: clinical applications in oncology. Part 1.Anatomical and functional imaging of tumors in animal models: focus on pheochromocytoma.Glucagon-Like Peptide-1 Receptor Imaging with [Lys (40) (Ahx-HYNIC- (99 m) Tc/EDDA)NH 2 ]-Exendin-4 for the Diagnosis of Recurrence or Dissemination of Medullary Thyroid Cancer: A Preliminary Report.Molecular imaging of neuroendocrine tumorsImaging with non-FDG PET tracers: outlook for current clinical applications.Role of PET/CT in the functional imaging of endocrine pancreatic tumors.Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 fluorodeoxyglucose positron emission tomography: a meta-analysis.18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their typeDepicting medullary thyroid cancer recurrence: the past and the future of nuclear medicine imaging.Diagnosis and preoperative imaging of multiple endocrine neoplasia type 2: current status and future directions.Role of (18) F-FDOPA PET/CT imaging in endocrinology.Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomographyClinical challenges with calcitonin-negative medullary thyroid carcinoma.On the use of [18F]DOPA as an imaging biomarker for transplanted islet mass.(18)F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma.Fluorine-18 labeled amino acids for tumor PET/CT imagingC-F Bond Formation for the Synthesis of Aryl Fluorides.PET Imaging in Recurrent Medullary Thyroid Carcinoma.Diagnosis in medullary thyroid cancer with [18F]FDG-PET and improvement using a combined PET/CT scanner.Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component.Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study.Diagnostic utility of PET/CT with 18F-DOPA and 18F-FDG in persistent or recurrent medullary thyroid carcinoma: the importance of calcitonin and carcinoembryonic antigen cutoff.68Ga-DOTATATE PET/CT in recurrent medullary thyroid carcinoma: a lesion-by-lesion comparison with 111In-octreotide SPECT/CT and conventional imaging.Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinomaEvolving paradigms for successful molecular imaging of medullary thyroid carcinomaDiagnostic accuracy of [18F]DOPA PET and PET/CT in patients with neuroendocrine tumors: a meta-analysis
P2860
Q26851709-1F1A1C87-038D-4B9E-9CF5-A04C9D14DE39Q34255457-D7154423-A86B-4EDF-ACF0-1E9B47B458F8Q34310219-3D3B6D8E-2592-4618-B4A3-66A04019D859Q34468665-21BA8EE3-F61C-4233-BF7B-8B7D914063D5Q35155742-1C1490D5-2A09-4437-8AD2-4BE7339A8652Q35544816-8719F08D-E214-4757-B374-A1E510747562Q35979079-B13380B9-D5DB-4732-A86F-7CB2B4F8DDDEQ36301116-82B8D99B-510D-4488-97F9-04A0FCDA1DF3Q36334917-BF4335DD-6D87-4D1F-977C-A7CD68DB503EQ36652807-1E5D0D76-119F-4C5D-A4FF-93F47CCF126AQ36765871-6498F3FE-F2BA-4B14-A92E-0E760C59509AQ37730951-C7B66776-3CB5-49A6-97C4-52D361A9E374Q37986065-E4E368B0-3201-4901-9B2A-75468D9F5591Q37994083-453B77A3-8EA4-4D2E-B777-C55B8A12B46CQ38004952-D8519EC0-BF28-45F0-84F4-57032AB1BE5CQ38082417-3F12EB7D-1242-4767-9657-8913D4A9336AQ38203509-3A015C61-5E2E-4BCF-8644-D99E38B994E5Q38217012-B9C9197F-BD3B-4304-9CD0-F9E9E7CA70A5Q38233342-9650283D-DD62-4C14-A0F6-50BAC1F4D5D1Q38248262-CCA776A9-BFB7-43CF-B3D0-77FF6EDD78E6Q38820275-8A52268B-0472-483F-86D2-7EC0FA694B86Q39069363-C2B5BB9A-0C99-4F27-88B1-11F512AEE160Q40397059-29A612D4-D797-47E8-B672-0CFCBCF88239Q41694062-E21EE6AB-2919-4E40-B97D-192F5DAB846EQ41974943-CD4C928C-B57B-4679-AE9B-67D990DB627DQ42254140-05F896D3-F11B-4686-AC45-4F7AFF61EE58Q44296937-84C8EE58-A8CF-4BE7-8107-202623E8EBE9Q44647880-C8879893-3E70-4FAD-A58F-D238D9114BE5Q45384072-DC43EEAF-89CA-4060-8BF5-F80799408550Q48227522-3185019E-C756-449E-B6C8-D0BDA65131B4Q52944867-64D050DB-B074-4385-97D6-70669C0CCF41Q57998575-80EEBC4C-C227-49DC-B37C-5B7DB6EB66A4Q57998577-E8E698DB-521E-4C65-AA8A-CF5997287556Q58005428-353C2B6F-7BD2-4610-B7FD-94B517500AE3
P2860
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
18F-DOPA positron emission tom ...... nd elevated calcitonin levels.
@ast
18F-DOPA positron emission tom ...... nd elevated calcitonin levels.
@en
type
label
18F-DOPA positron emission tom ...... nd elevated calcitonin levels.
@ast
18F-DOPA positron emission tom ...... nd elevated calcitonin levels.
@en
prefLabel
18F-DOPA positron emission tom ...... nd elevated calcitonin levels.
@ast
18F-DOPA positron emission tom ...... nd elevated calcitonin levels.
@en
P2093
P356
P1476
18F-DOPA positron emission tom ...... nd elevated calcitonin levels.
@en
P2093
P2888
P356
10.1007/S002590000404
P577
2001-01-01T00:00:00Z
P6179
1018415975